Skip to main content

Table 2 Her4 isoform-specific primers and probes

From: The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

JM-a Forward 5′-CCA CCC ATC CCA TCC AAA-3′
  Reverse 5′-CCA ATT ACT CCA GCT GCA ATC A-3′
  Probe 5′-Fam-ATG GAC GGG CAA TTC CAC TTT ACC A-Dabcyl-3′
JM-b Forward 5′-CCA CCC ATC CCA TCC AAA-3′
  Reverse 5′-CCA ATT ACT CCA GCT GCA ATC A-3′
  Probe 5′-Fam-CTC AAG TAT TGA AGA CTG CAT CGG CCT GAT-Dabcyl-3′
CYT1 Forward 5′-CAA CAT CCC ACC TCC CAT CTA TAC-3′
  Reverse 5′-ACA CTC CTT GTT CAG CAG CAA A-3′
  Probe 5′-Fam-TGA AAT TGG ACA CAG CCC TCC TCC TG-Dacyl-3′
CYT2 Forward 5′-CAA CAT CCC ACC TCC CAT CTA TAC-3′
  Reverse 5′-ACA CTC CTT GTT CAG CAG CAA A-3′
  Probe 5′-Fam-AAT TGA CTC GAA TAG GAA CCA GTT TGT ATA CCG AGA T-Dabcyl-3